Novo Nordisk has been granted marketing authorization by the European Commission for a new injectable, Xultophy, for the…
IDegLira
New Tresiba/Victoza Combination Therapy, IDegLira, Shows Improved Glucose Control and Weight Loss
IDegLira is a combination of Tresiba (insulin degludec), a once-daily basal insulin analogue with an ultra-long duration…
